LOGIN - EMDR: Eye Movement Desensitization and Reprocessing (EMDR) in Non-specific Chronic Back Pain
Study Details
Study Description
Brief Summary
The study explores the feasibility of Eye-Movement-Desensitization and Reprocessing (EMDR) in non-specific chronic back pain.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
The study explores the feasibility of Eye-Movement-Desensitization and Reprocessing (EMDR) in non-specific chronic back pain in a randomized controlled trial (RCT) with 6 months follow-up. The treatment consists of 12-sessions EMDR a 60 minutes using eye-movements for bilateral stimulation in addition to treatment as usual (TAU) that is compared to TAU alone.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Eye-Movement-Desensitization-Reprocessing Eye-Movement-Desensitization-Reprocessing |
Behavioral: Eye-Movement-Desensitization-Reprocessing
|
No Intervention: Treatment as usual (control group) treatment as usual |
Outcome Measures
Primary Outcome Measures
- Change in pain intensity [Change from Baseline Pain intensity at average 6 months]
Numerical rating scale 0-10
Other Outcome Measures
- functional and structural changes in fMRI [Change from Baseline fMRI at average 6 months]
- Change in the pain experience scale - Pain affect [Change from Baseline pain experience scale levels at average 6 months]
Geisser et al., 1996
- Change in the Hannover functional ability questionnaire (FFbH) - disability [Change from Baseline disabilty levels at average 6 months]
Kohlmann et al., 1996
- Change in Quantitative sensory testing (QST)profiles [Change from Baseline QST profile at average 6 months]
According to the protocol by Rolke et al. (2006), developed within the Germany Research Network on Neuropathic Pain (DFNS)
- Change in Conditioned Pain Modulation [Change from Baseline conditioned pain modulation activity at average 6 months]
difference in pressure pain threshold before and after oscillating heat (2 min.)
- Change in Plasma endocannabinoids and lipids [Change from Baseline endocannabinoids and lipids at average 6 months]
Plasma levels: AEA (ng/ml), 2-AG (ng/ml), AA (ng/ml), PEA (ng/ml), OEA (ng/ml), AEA (pmol/g), 2-AG (pmol/g), AA (nmol/g), PEA (pmol/g), OEA (pmol/g),
- Change in plasma nerve growth factor levels [Change from Baseline NGF levels at average 6 months]
Plasma levels in (pg/ml)
- Change in pain drawing/ the spatial extent of the pain [Change from Baseline Pain extent at average 6 months]
- Change in West Haven-Yale multidimensional pain inventory scores [Change from Baseline West Haven-Yale multidimensional pain inventory scores at average 6 months]
Flor et al., 1990
- Change in chronic pain grade [Change from Baseline chronic pain grade at average 6 months]
von Korff er al., 1992
- Change in Resilience Scale (RS-11) scores [Change from Baseline resilience scores at average 6 months]
Schumacher et al., 2004
- Change in Hospital Anxiety and Depression Scale scores [Change from Baseline anxiety and depression levels at average 6 months]
Zigmond & Snaith, 1983
- Change in Health Survey scores [Change from baseline quality of life level at average 6 months]
SF-12
- Change in somatization scores [Change from Baseline somatization scores at average 6 months]
SCL-90R
- Change in medication intake [Change from Baseline medication intake at average 6 months]
- Change in dissociation scores [Change from Baseline dissociation at average 6 months]
DES/FDS-20
- Change in Post Traumatic Diagnostic Scale [Change from Baseline post traumatic diagnostic scale levels at average 6 months]
- Patient global impression of change [after on average 6 months of treatment]
- Recruitment potential [6 months]
% of patients eligible for inclusion that give written informed consent
- Retention rate [over average 6 months of treatment]
% of patients that finish treatment, including pre- and post-evaluation
Eligibility Criteria
Criteria
Inclusion Criteria:
-
= 18 years
-
non-specific chronic low back pain >= 45 days/3 months
-
high emotional distress caused by psychological trauma
-
German language skills
Exclusion Criteria:
-
specific causes of chronic back pain
-
application for retirement pension pending
-
ongoing psychotherapy
-
severe physical or psychiatric comorbidity
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University Hospital Heidelberg | Heidelberg | Baden-Württemberg | Germany | 69120 |
Sponsors and Collaborators
- University Hospital Heidelberg
Investigators
- Principal Investigator: Wolfgang Eich, Prof. Dr., University Hospital Heidelberg
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- 01EC1010A